Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Shares of Alexion Pharmaceuticals, Inc. (ALXN) are currently surging over 30% after AstraZeneca agreed to acquire the company.


RTTNews | Dec 14, 2020 09:58AM EST

09:58 Monday, December 14, 2020 (RTTNews.com) - Shares of Alexion Pharmaceuticals, Inc. (ALXN) are currently surging over 30% after AstraZeneca agreed to acquire the company.

ALXN is currently trading at $157.77, up $36.79 or 30.41%, on the Nasdaq.

AstraZeneca will pay around $175 per share for Alexion, through a combination of cash and shares, valuing the Boston-based group at $39 billion. This represents about 45% premium to Alexion's Friday closing price.

Alexion shareholders will own around 15% of AstraZeneca's outstanding shares when the deal closes in the third quarter of next year.

Alexion lifted its 2020 revenue guidance in October, and set a 2025 target of between $9 billion and $10 billion in annual sales.

Read the original article on RTTNews ( https://www.rttnews.com/3153466/stock-alert-alexion-pharmaceuticals-jumps-30-on-astrazeneca-takeover.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC